We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-0.27%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.92B
AUM Growth
+$75.1M
Cap. Flow
+$135M
Cap. Flow %
3.46%
Top 10 Hldgs %
32.39%
Holding
6,700
New
1,026
Increased
2,252
Reduced
2,490
Closed
691

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$19.9M
2
SOXX icon
iShares Semiconductor ETF
SOXX
+$19M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$18.2M
4
CRM icon
Salesforce
CRM
+$16.1M
5
TSLA icon
Tesla
TSLA
+$14.7M

Sector Composition

Rank Sector Weight
1 Technology 18.5%
2 Consumer Discretionary 8.04%
3 Healthcare 7.14%
4 Communication Services 6.4%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PUCK
4901
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
$5K ﹤0.01%
487
-517
-51% -$4.99K
AVGR
4902
DELISTED
Avinger, Inc. Common Stock
AVGR
$5K ﹤0.01%
23
NBSE
4903
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$5K ﹤0.01%
71
-194
-73% -$14.8K
VAQC
4904
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$5K ﹤0.01%
495
ALYA
4905
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$5K ﹤0.01%
+1,948
New +$5.47K
BETS
4906
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
0
AUVI
4907
DELISTED
Applied UV, Inc. Common Stock
AUVI
$5K ﹤0.01%
6
-35
-85% -$33.6K
CCVI.U
4908
DELISTED
Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CCVI.U
$5K ﹤0.01%
467
+431
+1,197% +$4.35K
BOAC.U
4909
DELISTED
Bluescape Opportunities Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant
BOAC.U
$5K ﹤0.01%
462
+24
+5% +$247
PTRA
4910
DELISTED
Proterra Inc. Common Stock
PTRA
$5K ﹤0.01%
500
-11,437
-96% -$129K
ARBGU
4911
DELISTED
Aequi Acquisition Corp Unit
ARBGU
$5K ﹤0.01%
508
-5
-1% -$50
MLVF
4912
DELISTED
Malvern Bancorp, Inc.
MLVF
$5K ﹤0.01%
+316
New +$5.72K
JUGGU
4913
DELISTED
Jaws Juggernaut Acquisition Corporation Unit
JUGGU
$5K ﹤0.01%
501
-9
-2% -$90
SKYA
4914
DELISTED
Skydeck Acquisition Corp. Class A Ordinary Shares
SKYA
$5K ﹤0.01%
+543
New +$5.25K
LGACU
4915
DELISTED
Lazard Growth Acquisition Corp. I Units
LGACU
$5K ﹤0.01%
535
+150
+39% +$1.49K
CTAQ
4916
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
$5K ﹤0.01%
539
+517
+2,350% +$5.02K
RBCN
4917
DELISTED
Rubicon Technology, Inc.
RBCN
$5K ﹤0.01%
442
-705
-61% -$6.71K
AGCB
4918
DELISTED
Altimeter Growth Corp 2
AGCB
$5K ﹤0.01%
504
+405
+409% +$4.03K
PAFOU
4919
DELISTED
Pacifico Acquisition Corp. Units
PAFOU
$5K ﹤0.01%
+510
New +$5.14K
GSEV
4920
DELISTED
Gores Holdings VII, Inc. Class A Common Stock
GSEV
$5K ﹤0.01%
+554
New +$5.46K
BSKYU
4921
DELISTED
Big Sky Growth Partners, Inc. Unit
BSKYU
$5K ﹤0.01%
455
ZWRKU
4922
DELISTED
Z-Work Acquisition Corp. Units
ZWRKU
$5K ﹤0.01%
476
+64
+16% +$635
TSIB
4923
DELISTED
Tishman Speyer Innovation Corp. II Class A common stock
TSIB
$5K ﹤0.01%
+539
New +$5.28K
FLACU
4924
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$5K ﹤0.01%
470
LOGC
4925
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$5K ﹤0.01%
1,145
-2,465
-68% -$10.8K

Similar funds

Tower Research Capital (TRC)'s Q3 2021 Portfolio in Review

As of Q3 2021, Tower Research Capital (TRC) held 6,700 positions worth $3.92B, up 2% from $3.84B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) deployed $135M of net new capital in Q3 2021, opening 1,026 new positions and adding to 2,252 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $19.9M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2021 buy was Vanguard S&P 500 ETF: 107,857 shares worth $42.5M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $342M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2021 reduction was UnitedHealth, cutting an estimated $19.9M.
  • Tower Research Capital (TRC) fully exited iShares Semiconductor ETF in Q3 2021, selling an estimated $19M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $3.92B portfolio in Q3 2021.
  • Tower Research Capital (TRC) opened 1,026 new positions and closed 691 in Q3 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 2% quarter-over-quarter to $3.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2021, filed 15 Nov 2021.